 |
Amneal Pharmaceuticals
AMRX
|
882 M |
$ 12.32 |
- |
$ 3.86 B |
USA |
 |
Acorda Therapeutics
ACOR
|
228 M |
- |
-24.86 % |
$ 820 K |
USA |
 |
Adverum Biotechnologies
ADVM
|
22.9 M |
- |
- |
$ 86.2 M |
USA |
 |
AlloVir
ALVR
|
9.71 M |
- |
4.14 % |
$ 49.1 M |
USA |
 |
Applied Molecular Transport
AMTI
|
15.1 M |
- |
- |
$ 10.1 M |
USA |
 |
Applied Therapeutics
APLT
|
71.2 M |
- |
- |
$ 8.42 M |
USA |
 |
I-Mab
IMAB
|
576 M |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B |
- |
- |
$ 40.3 B |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
130 M |
$ 23.27 |
- |
$ 2.96 B |
USA |
 |
Autolus Therapeutics plc
AUTL
|
73.4 M |
$ 1.36 |
- |
$ 362 M |
Britain |
 |
AVROBIO
AVRO
|
6.35 M |
- |
1083.1 % |
$ 745 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
7.54 M |
- |
- |
$ 7.46 M |
Israel |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Cabaletta Bio
CABA
|
50.2 M |
$ 3.07 |
- |
$ 308 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
1.83 B |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
CymaBay Therapeutics
CBAY
|
36.8 M |
- |
- |
$ 3.45 B |
USA |
 |
Advaxis
ADXS
|
25 M |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.05 M |
$ 3.03 |
- |
$ 6.59 B |
Israel |
 |
Aytu BioScience
AYTU
|
63.1 M |
$ 2.57 |
-3.38 % |
$ 16.1 M |
USA |
 |
Avid Bioservices
CDMO
|
70.6 M |
- |
- |
$ 789 M |
USA |
 |
Cidara Therapeutics
CDTX
|
49.6 M |
- |
- |
$ 1.41 B |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
556 M |
- |
- |
- |
Russia |
 |
Checkpoint Therapeutics
CKPT
|
20.1 M |
- |
- |
$ 169 M |
USA |
 |
Checkmate Pharmaceuticals
CMPI
|
9.38 M |
- |
- |
$ 231 M |
USA |
 |
AgeX Therapeutics
AGE
|
3.56 M |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Concert Pharmaceuticals
CNCE
|
16.1 M |
- |
- |
$ 401 M |
USA |
 |
Cellectar Biosciences
CLRB
|
4.75 M |
$ 2.75 |
- |
$ 7.17 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
58.7 M |
- |
- |
$ 1.01 B |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
25.2 M |
- |
- |
$ 26.5 M |
USA |
 |
CTI BioPharma Corp.
CTIC
|
81.1 M |
- |
- |
$ 1.2 B |
USA |
 |
AIkido Pharma
AIKI
|
1.61 M |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Aptose Biosciences
APTO
|
9.31 M |
- |
-45.71 % |
$ 1.2 M |
Canada |
 |
Cyclacel Pharmaceuticals
CYCCP
|
1.33 M |
- |
-4.36 % |
$ 27 M |
USA |
 |
Deciphera Pharmaceuticals
DCPH
|
100 M |
- |
- |
$ 2.18 B |
USA |
 |
Akero Therapeutics
AKRO
|
39.8 M |
- |
- |
$ 3.67 B |
USA |
 |
Dynavax Technologies Corporation
DVAX
|
78.6 M |
- |
- |
$ 2.02 B |
USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
20.7 M |
$ 9.71 |
- |
$ 129 M |
USA |
 |
Curis
CRIS
|
14.1 M |
$ 0.55 |
0.09 % |
$ 7.24 M |
USA |
 |
Coherus BioSciences
CHRS
|
140 M |
$ 1.67 |
- |
$ 196 M |
USA |